We found 6 specific proteins (NTRK2, MAPKAPK2, JUND, CRK, PPP3R1, and NFATC2) of the MAPK pathway, which participate in the progression of HCC from stage I to stage II. Here, CRK is linked to hepatocellular carcinoma.